|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Eurekalert Medical and Health News Archives
Eurekalert Medical and Health News: 12-06-2004
researchers at the Stanford University School of Medicine have developed a technique that can virtually eliminate this life-threatening complication, known as graft-versus-host disease, without compromising the transplanted cells' effectiveness against cancer.
Beginning today, Endo Pharmaceuticals Inc. will initiate commercial shipments of the first and only single-dose epidural injection that can provide up to 48 hours of pain control to help ease pain for people undergoing major surgery in the United States.
Babies who never sleep on their stomachs don't learn behaviors that may lessen their risk of sudden infant death syndrome (SIDS), researchers at Washington University School of Medicine in St. Louis have found. Even so, the researchers caution that infants should always be placed on their backs to sleep.
Diabetics with mental disorders do not have as good blood sugar control as diabetics without mental illness and are more likely to suffer diabetes complications than diabetics without mental illness.
Blacks and poor individuals are more likely to be donors while whites and wealthier individuals are more likely to be recipients of many types of transplant organs, according to a new study in the November 2004 issue of the American Journal of Medicine.
A new approach to aircraft scheduling that uses computer models could allow a safe increase in airport throughput and reduce pollution. The system under development would, for the first time, provide runway controllers with advice, based on state-of-the-art computer models, on the most efficient, safe sequence in which aircraft can take-off.
Crunched for time, many parents are sending their children off to school without breakfast, but a trial program instituted in a Pennsylvania school may not only feed those in a rush, but better provide for those entitled to free and reduced price meals, according to Penn State researchers.
Data on tipifarnib (R115777), a compound under investigation by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. for the treatment of elderly patients with newly diagnosed poor-risk acute myeloid leukemia (AML), were presented at the 46th annual meeting of the American Society of Hematology (ASH).
New research from the University of Pittsburgh shows it is not easy for the human body to adjust to dramatic time changes as experienced by those who work shifts or whose travel takes them across time zones.
A surgical procedure being pioneered by University College London (UCL) urologists is enabling men born with a very small penis to acquire an average-sized, functioning penis which not only allows them to urinate normally, but for many, to enjoy a full sex life for the first time.
Doctors appear willing to use intensive treatment to lessen otherwise untreatable pain or other severe symptoms in dying patients even if the treatment, at least in theory, risks hastening the dying process, according to two studies. Known as "terminal sedation," the practice may risk, but does not intend, hastening or causing death. A majority of physicians drew a clear line between terminal sedation and assisted suicide. The research also revealed factors related to physicians' attitudes.
Children watching commercials aired during televised sports events may frequently be exposed to violent and unsafe behavior, a study by a Penn State Children's Hospital physician suggests.
Generic drug use varies widely by state, according to a new Express Scripts study that measured per capita generic drug utilization in 2003 using a random sample of approximately 3 million pharmacy benefit plan members age 18 to 64.The study revealed that Massachusetts had the highest generic dispensing rate, at 51%. New Jersey used generics for fewer than 40% of all prescriptions.
Researchers at Cedars-Sinai Medical Center have found that a small protein called hsFlt3L delivered via a genetically engineered virus increased the number of immune cells in the brain and significantly slowed tumor growth, increasing the survival of laboratory rats in pre-clinical studies.
CHU in Poitiers, France, today announced results of a study showing that newly diagnosed patients with a certain form of leukemia who are treated early with imatinib are more likely to achieve complete cytogenetic responses (the elimination of leukemic cells, a major goal of therapy) and have improved long-term outcomes.
HIV-positive women with low blood platelet counts face significantly higher risk of death compared to women with normal counts, according to a study presented today at the 46th Annual Meeting of the American Society of Hematology.
The 10 percent of children with sickle cell disease who are at risk for a stroke need ongoing blood transfusions to reduce their risk, according to a study at 25 sites in North America.
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has stopped early a clinical trial studying whether children with sickle cell anemia at high risk for stroke could at some point after a minimum of 30 months safely stop receiving the periodic blood transfusions that prevent strokes. The study found a return to high risk of stroke in children who stopped receiving the transfusions. The NHLBI is issuing a clinical alert on the study's results to inform physicians.
Contrary to long-accepted scientific thought, researchers have found that handedness is not associated with the language area of the brain. Rather, handedness is associated with the KNOB, the area of the brain known for controlling hand movements in primates and, now, for determining handedness in chimpanzees.
A University of Minnesota Cancer Center study indicates natural killer cells obtained from a family member and artificially stimulated may provide renewed hope for some patients who have advanced acute myelogenous leukemia (AML), a highly fatal cancer of the bone marrow, that has become resistant to standard treatment with chemotherapy.
Two different novel targeted therapies can produce strong responses in patients who have become resistant to Gleevec(tm), the standard therapy for chronic myeloid leukemia (CML), researchers at The University of Texas M. D. Anderson Cancer Center are reporting.
An experimental drug under development by Bristol-Myers Squibb is showing early promise in reversing the signs and symptoms of patients whose chronic myeloid leukemia failed to respond to Gleevec, which is considered the standard of treatment for the disorder.
A biocide found in many shampoos and hand lotions and widely used in industrial settings inhibits the development of neuron structures that are essential for transmitting signals between cells, according to a University of Pittsburgh study presented today Cell Biology 2004. Prolonged exposure to low levels of methylisothiazolinone restricted growth of axons and dendrites of immature rat nerve cells in culture and may have potentially damaging consequences to a developing nervous system.
The University of Texas M. D. Anderson Cancer Center offers these news items presented at the annual meeting of the American Society of Hematology (ASH).
A University of Oregon researcher who believes consumers should be partners in improving the nation's health care system will serve on the National Advisory Council for Healthcare Research and Quality (NACHRQ).
|
|
